Tesla and NatPower Partner on $5 Billion Battery Storage Expansion in Europe 
100+ Global Companies Push Governments to Prioritize Electrification for Economic Growth 
Heineken Names JDE Peet’s CEO Rafael Oliveira as New Chief Executive 
China Adds MP Materials, USA Rare Earth to Export Control List Amid Escalating U.S.-China Trade Tensions 
Baseten Secures $1.5 Billion Funding at $13 Billion Valuation Amid AI Infrastructure Boom 
SpaceX Stock Plunges 16% as KeyBanc Warns Valuation May Be Overstretched 
Tencent Reviews Marvelous Stake as Gaming Giant Reassesses Global Investment Strategy 
Meta Reportedly Developing ‘Arena’ Prediction Market App to Rival Polymarket and Kalshi 
US-Iran De-Escalation Shifts Washington’s Focus to AI Regulation and Crypto Legislation 
Alphabet Replaces Verizon in Dow Jones Industrial Average 
Oracle Cuts 21,000 Jobs as AI Reshapes Workforce and Cloud Expansion Accelerates 
Apollo Debt Solutions Limits Redemptions as Withdrawal Requests Surge 
Cerebras Revenue Forecast Tops Expectations, but Margin Concerns Weigh on Stock 
Google’s Open-Source AI Data Center Cooling Design Raises Commoditization Concerns 
NHTSA Investigates Fatal Tesla Model 3 Crash in Texas Amid Ongoing Autopilot and FSD Safety Scrutiny 
Nissan Halts Electric Qashqai Development Amid EV Market Challenges 
NEW ORLEANS, Feb. 05, 2016 -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until April 4, 2016 to file lead plaintiff applications in a securities class action lawsuit against Insys Therapeutics, Inc. (Nasdaq:INSY), if they purchased the Company’s securities between March 3, 2015 and January 25, 2016, inclusive (the “Class Period”). This action is pending in the United States District Court for the District of Arizona.
What You May Do
If you purchased shares of Insys and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, call toll-free at 1-877-515-1850 or email KSF Managing Partner Lewis Kahn ([email protected]). If you wish to serve as a lead plaintiff in this class action, you must petition the Court by April 4, 2016.
About the Lawsuit
Insys and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
The alleged false and misleading statements included, but are not limited to, that: (i) Insys was engaged in the illegal and improper off-labeling marketing of Subsys; (ii) certain Insys employees—including the President and Chief Executive Officer of Insys during much of the Class Period—were complicit in an illegal kickback scheme operated for the purpose of increasing prescriptions of Subsys; and (iii) as a result, Insys’s financial statements were materially false and misleading at all relevant times.
About Kahn Swick & Foti, LLC
KSF, whose partners include the Former Louisiana Attorney General Charles C. Foti, Jr., is a law firm focused on securities, antitrust and consumer class actions, along with merger & acquisition and breach of fiduciary litigation against publicly traded companies on behalf of shareholders. The firm has offices in New York, California and Louisiana.
To learn more about KSF, you may visit www.ksfcounsel.com.
Contact: Kahn Swick & Foti, LLC Lewis Kahn, Managing Partner [email protected] 1-877-515-1850 206 Covington St. Madisonville, LA 70447
